OR WAIT null SECS
Covance Inc. (NYSE:CVD), a leading provider of drug development services, announced today that it signed a definitive agreement with Eli Lilly and Company (NYSE: LLY) to help transform Lilly's R&D model.
COVANCE AND LILLY ENTER INTO A STRATEGIC R&D COLLABORATION
COVANCE AND ELI LILLY –
STRATEGIC PARTNERSHIP TO ACCELERATE DRUG DEVELOPMENT
Who are the players?